He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

New research has found that over 1,100 people in the UK develop lung cancer each year due to air pollution, with the most common subtype, adenocarcinoma, linked to toxic air exposure.

Although lung cancer has been the leading cause of lung-cancer death globally for decades, there are important temporal and geographical differences in lung-cancer incidence, mortality, and other ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

Jared Fischer, Ph.D., and Jose Luis Montoya Mira, Ph.D., cancer researchers at Oregon Health & Science University, have developed PAC-MANN, a test that uses a small blood sample to detect changes in ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

Pancreatic cancer is one of the deadliest types of cancer, with very few people surviving for more than five years after ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

Senescent cells, or ‘zombie’ cells, are damaged cancer cells that remain active, making it harder to treat tumors.

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...